Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines

Prostate

Volumn 34, Issue 2, 1998, Pages 80-91

  Savarese, Diane M F ^a   Valinski, Helen ^a   Quesenberry, Peter ^a   Savarese, Todd ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

G CSF; GM CSF; Hematopoietic colony stimulating factors; M CSF; Prostate cancer; SCF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; BONE METASTASIS; CARCINOMA CELL; CELL DEATH; CELL LINE; CELL STIMULATION; CHEMOTAXIS; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0031890810     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980201)34:2<80::AID-PROS2>3.0.CO;2-N     Document Type: Article

References (62)

1. Nicola NA: Hematopoietic cell growth factors and their receptors. Annu Rev Biochem 1983;58:45-77.
2. Jacobs SC: Spread of prostate cancer to bone. Urology 1983;21: 337-344.
3. Berrettoni BA, Carter JR: Mechanisms of cancer metastasis to bone. J Bone Joint Surg (Am) 1986;68:308-312.
4. Chackal-Roy M, Niemeyer C, Moore M, Zetter BR: Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 1989;84:43-50.
5. Lang SH, Miller WR, Duncan W, Habib FK: Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int J Cancer 1994;59:235-241.
6. Aznavoorian S, Stracke ML, Krutzch H, Schiffman E, Liotta LA: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 1990;110:1427-1438.
7. Djakiew D, Pflug BR, Delsite R, Onoda M, Lynch JH, Arand G, Thompson EW: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 1993;53:1416-1420.
8. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990;87:9655-9659.
9. Kitamura T, Sato N, Arai K, Miyajima A: Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991;66:1165-1174.
10. Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB: Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 1996;16:557-564.
11. Lotem J, Sachs L: Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemia cells. Blood 1992;80: 1750-1757.
12. Duke RC, Cohen JJ: IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 1986;5:289-299.
13. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, Aglietta M, Arese P, Mantovani A: Granulocyte-and granulocyte-macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989;337: 471-473.
14. Horiguchi J, Sherman ML, Sampson-Johannes A, Weber BL, Kufe DW: CSF-1 and c-fms gene expression in human carcinoma cell lines. Biochem Biophys Res Commun 1988;157:395-401.
15. Kawasaki ES, Ladner MB, Wang AM, Van Arsdell J, Warren MK, Coyne MY, Schweikart VL, Lee MT, Wilson KJ, Boosman A, Stanley ER, Ralph P, Mark DF: Molecular cloning of a complementary DNA encoding human macrophage specific colony stimulating factor (CSF-1). Science 1985;230:291-296.
16. Kacinski BM, Carter D, Mittal K, Yee LD, Scata KA, Donofrio L, Chambers SK, Wang K, Yang-Feng T, Rohrschneider LR, Rothwell VM: Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol 1990;137:135-147.
17. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jone MA, Pirro MH, Stanley ER, Rohrschneider LR: FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 1991;6:941-952.
18. Ramakrishnan S, Xu FJ, Brandt SJ, Niedel JE, Bast RC Jr, Brown EL: Constitutive production of macrophage colony stimulaing factor by human ovarian and breast cancer cell lines. J Clin Invest 1989;83:921-926.
19. Devlin JJ, Devlin PE, Myambo K, Lilly MB, Rado TA, Warren MK: Expression of granulocyte colony stimulating factor by human cancer cells. J Leukocyte Biol 1987;41:302-306.
20. Lilly MB, Devlin PE, Devlin JJ, Rado TA: Production of granulocyte colony-stimulating factor by a human melanoma cell line. Exp Hematol 1987;15:966-971.
21. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G: Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res 1994;54:3049-3053.
22. Stan A-C, Walter GF, Welte K, Pietsch T: Immunolocalization of granulocyte colony-stimulating factor in human glial and primitive neuroectodermal tumors. Int J Cancer 1994;57:306-312.
23. Gabrilove JL, Welte K, Harris P, Platzer E, Lu L, Levi E, Mertelsmann R, Moore MAS: Pluripoietin α: A second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. Proc Natl Acad Sci USA 1986; 83:2478-2482.
24. Hines SJ, Organ C, Kornstein MJ, Krystal GW: Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995;6:769-779.
25. Obara T, Ito Y, Kodama T, Fujimoto Y, Mizoguchi H, Oshimi K, Takahashi M, Hirayama A: A case of gastric carcinoma associated with excess granulocytosis. Cancer 1985;56:782-788.
26. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992;80:374-381.
27. Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ: Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 1991;51:1811-1816.
28. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A: Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 1992;52:6139-6143.
29. Sekido Y, Takahashi T, Ueda R, Takahashi M, Suzuki H, Nishida K, Tsukamoto Y, Hida T, Shimokata K, Zsebo KM, Takahashi T: Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res 1993;53:1709-1714.
30. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, Takahashi T, Ueda R: Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993; 142:339-346.
31. Hida T, Ueda R, Sekido Y, Hibi K, Matsuda R, Ariyoshi Y, Sugiura T, Takahashi T, Takahashi T: Ectopic expression of c-kit in small cell lung cancer. Int J Cancer [Suppl] 1994;8:108-109.
32. Worm M, Reichert U, Dippel E, Czarnetzki BM, Schadendorf D: Expression of growth factor receptors on human melanoma cells: Comparison of modulating effects of interferons and retinoids. Exp Dermatol 1993;2:217-223.
33. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC: Expression of stem cell factor and c-kit in human neuroblastoma. Blood 1994;84:3465-3472.
34. Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J, Ludwig WD, Kreuser ED, Thiel E, Herrmann F: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 1992;52:3498-3502.
35. Bokemeyer C, Kuczyk MA, Dunn T, Serth J, Hartmann K, Jonasson J, Pietsch T, Jonas U, Schmoll H-J: Expression of stem cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol 1996; 122:301-306.
36. Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF: Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989;73:80-83.
37. Dedhar S, Gaboury L, Galloway P, Eaves C: Human granulocyte-macrophage colony stimulating factor is a growth factor active on variety of cell types of nonhematopoietic origin. Proc Natl Acad Sci USA 1988;85:9253-9257.
38. Block T, Schmid F, Geffken B, Treiber U, Busch R, Hartung R: Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage-and granulocyte-colony stimulating factor. Urol Res 1992;20:289-292.
39. Foulke RS, Marshall MH, Trotta PP, Von Hoff DD: In vitro assessment of the effects of granulocyte-macrophage colony stimulating factor on primary human tumors and derived lines. Cancer Res 1990;50:6264-6267.
40. Salmon SE, Liu R: Effects of granulocyte-macrophage colony stimulating factor on in vitro growth of human solid tumors. J Clin Oncol 1989;7:1346-1350.
41. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, DiPersio JF: Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989,74:1033-1037.
42. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R: Expression of the macrophage colony stimulating factor and its receptor in gynecologic malignancies. Cancer 1991;67:990-996.
43. Kacinski BM, Carter D, Mittal K, Kohorn EI, Bloodgood RS, Donahue J, Donofrio L, Edwards R, Schwartz PE, Chambers JT, Chambers SK: High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 1988;15:823-829.
44. Tada M, Diserens A-C, Desbaillets I, de Tribolet N: Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 1994;80:1063-1073.
45. Wilding G, Valverius E, Knabbe C, Gelmann EP: Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 1989;15:1-12.
46. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E: Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol Cell Endocrinol 1989;62:79-87.
47. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50:7786-7788.
48. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW: Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996;56:663-668.
49. Young MRI, Young ME, Wright MA: Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors. Exp Hematol 1990;18:806-811.
50. Young MRI, Lozano Y, Coogan M, Wright MA, Young ME, Bagash JM: Stimulation of the metastatic properties of Lewis lung carcinoma cells by autologous granulocyte-macrophage colony stimulating factor. Int J Cancer 1992;50:628-634.
51. Partin AW, Schoeniger JS, Mohler JL, Coffey DS: Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989;86:1254-1258.
52. Lang SH, Miller WR, Habib FK: Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Prostate 1995;27:287-293.
53. Koutsilieris M, Rabbani SA, Goltzmann D: Selective osteoblast mitogens can be extracted from prostaric tissue. Prostate 1986; 9:109-115.
54. Perkel VS, Mohan S, Herring SJ, Baylink DJ, Linkhart TA: Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells. Cancer Res 1990; 50:6902-6907.
55. Evans DB, Bunning RAD, Russell RGG: The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells. Biochem Biophys Res Commun 1989;160:588-595.
56. Hofstetter W, Wetterwald A, Cecchini MC, Felix R, Fleisch H, Mueller C: Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA 1992;89:9637-9641.
57. Felix R, Cecchini MG, Fleisch H: Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 1990;127:2592-2594.
58. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
59. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
60. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF: Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer 1978;21:274-282.
61. Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP: Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer. J Clin Oncol 1996;14:1617-1625.
62. Sanda MG, Ayyagari SR, Jaffee EM, Epstein JI, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 1994;151:622-628.